PeptiDream has signed a deal with fellow Japanese pharmaceutical company Shionogi to discover and develop a series of blood-brain barrier...
Read moreTC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, announced it has completed...
Read moreAstellas Pharma Inc and KM Biologics Co., Ltd. announced that the agreement for the distribution by Astellas of human vaccines,...
Read moreNovartis has partnered with the University of Oxford’s Big Data Institute (BDI) to boost drug development using artificial intelligence (AI)...
Read moreNeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company focused on novel, disease-modifying therapies for neurodegenerative diseases announced its plans to initiate...
Read moreLabCorp, a leading global life sciences company, and GENFIT , a biopharmaceutical company focused on discovering and developing drug candidates...
Read moreClinical-stage company ImmusanT’s therapeutic vaccine candidate Nexvax2 has been granted fast track designation by the US FDA. ImmusanT uses its...
Read moreGilead Sciences announced that the National Medical Products Administration (NMPA) has approved Harvoni® (ledipasvir 90 mg/sofosbuvir 400 mg) in China...
Read moreStem Cell Medicine Ltd. (SCM), a biotechnology company developing new therapies for neurological indications, including mesenchymal stem cells and anti-BMP...
Read moreRoche announced that the US FDA approved Tecentriq in combination with Avastin, paclitaxel and carboplatin (chemotherapy), for the initial (first-line)...
Read morePharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.